diabetic macular edema therapeutic (Aciont)

N/A

Report date: 2025/01/26 19:00:14
NME

Base Information

Drug Namediabetic macular edema therapeutic (Aciont)
Drug Alias Namediabetic macular edema therapeutic (Aciont)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetic macular oedema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAciont Inc
China Registration ClassN/A

Develop Information

Active CompaniesAciont Inc
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedema
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A